scholarly journals Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11)

2014 ◽  
Vol 19 (16) ◽  
Author(s):  
J Mereckiene ◽  
S Cotter ◽  
A Nicoll ◽  
P Lopalco ◽  
T Noori ◽  
...  
Keyword(s):  
Older People ◽  
Influenza Vaccination ◽  
Pregnant Women ◽  
Vaccination Coverage ◽  
Healthcare Workers ◽  
Seasonal Influenza ◽  
Risk Groups ◽  
European Economic Area ◽  
Clinical Risk ◽  
The Impact

Since 2008, annual surveys of influenza vaccination policies, practices and coverage have been undertaken in 29 European Union (EU)/ European Economic Area (EEA) countries. After 2009, this monitored the impact of European Council recommendation to increase vaccination coverage to 75% among risk groups. This paper summarises the results of three seasonal influenza seasons: 2008/09, 2009/10 and 2010/11. In 2008/09, 27/29 countries completed the survey; in 2009/10 and 2010/11, 28/29 completed it. All or almost all countries recommended vaccination of older people (defined as those aged ≥50, ≥55, ≥59, ≥60 or ≥65 years), and people aged ≥6 months with clinical risk and healthcare workers. A total of 23 countries provided vaccination coverage data for older people, but only 7 and 10 had data for the clinical risk groups and healthcare workers, respectively. The number of countries recommending vaccination for some or all pregnant women increased from 10 in 2008/09 to 22 in 2010/11. Only three countries could report coverage among pregnant women. Seasonal influenza vaccination coverage during and after the pandemic season in older people and clinical groups remained unchanged in countries with higher coverage. However, small decreases were seen in most countries during this period. The results of the surveys indicate that most EU/EEA countries recommend influenza vaccination for the main target groups; however, only a few countries have achieved the target of 75% coverage among risk groups. Coverage among healthcare workers remained low.

scholarly journals Influenza vaccination coverage among healthcare workers during the first two seasons of data collection, Finland, 2017-2019

2020 ◽  
Author(s):  
Charlotte C Hammer ◽  
Outi Lyytikäinen ◽  
Dinah Arifulla ◽  
Toura Saija ◽  
Hanna Nohynek
Keyword(s):  
High Risk ◽  
Influenza Vaccination ◽  
Vaccination Coverage ◽  
Healthcare Workers ◽  
Risk Groups ◽  
Severe Illness ◽  
Immunocompromised Patients ◽  
Web Based ◽  
The Mean ◽  
Improve Patient

Background: Influenza can cause severe illness among high-risk groups such as elderly and immunocompromised patients. Mandatory influenza vaccination of healthcare workers (HCWs) has been viewed as means to improve patient and HCW protection. Methods: We analyzed data collected by a web-based survey sent annually to all Finnish acute care hospitals and described the influenza vaccination coverage among HCWs during seasons 2017/18 (without mandate) and 2018/19 (mandate enforced). Results: In season 2017/2018, 38/39 hospitals provided data and 35/36 hospitals in 2018/2019. The mean coverage in season 2017/18 was 88% (median, 84%; range 48-100%) and in 2018/19 91% (median, 91%; range 57-100%). The mean increase from season 2017/2018 to 2018/2019 was 6.5% (median, 3%; range -11.0-33.0%). Conclusions: The coverage of influenza vaccinated HCWs in Finnish hospitals was high. However, there were major differences between hospitals which raise the question about data quality as well as implementation of the mandate, and need further evaluation.

scholarly journals The scientific basis for offering seasonal influenza immunisation to risk groups in Europe

2008 ◽  
Vol 13 (43) ◽  
Author(s):  
A Nicoll ◽  
B C Ciancio ◽  
S Tsolova ◽  
P R Blank ◽  
C Yilmaz
Keyword(s):  
Older People ◽  
Healthcare Workers ◽  
Seasonal Influenza ◽  
Scientific Evidence ◽  
Care Home ◽  
Risk Groups ◽  
Scientific Basis ◽  
Adverse Outcomes ◽  
Average Risk ◽  
Eu Countries

This paper summarises the scientific evidence supporting selection of risk groups that would benefit from annual seasonal influenza immunisation in European Union (EU) countries. Risk groups are defined restrictively as persons in Europe at higher than average risk of adverse outcomes should they be infected with seasonal influenza and for whom use of vaccine is demonstrated to be effective in reducing the risk of those outcomes. Existing evidence indicate that older people and those with chronic disease are at higher risk of severe adverse outcome and that immunisation reduces this risk. There is thus good scientific evidence for routinely offering annual immunisation to all older people (at least those aged 65 years and older), and people with certain groups of chronic medical conditions. We estimated that these two groups account for between 19% and 28% of the population of EU countries. Thus in 2006, an estimated 84 million older people aged 65 years and over and 41 million people younger than 65 years of age with chronic conditions were living in these countries. There is also strong evidence for immunising staff caring for patients belonging to these two risk groups in residential (care home) settings in order to protect the patients. There are as yet no strong data on whether or not immunising other healthcare workers and carers protect patients though immunisation of healthcare workers can be justified on occupational health grounds. At present the scientific evidence for immunising other suggested risk groups, notably children and pregnant women is not strong for Europe though equally there is no evidence against immunising these groups.

scholarly journals Support among healthcare workers for the new mandatory seasonal influenza vaccination policy and its effects on vaccination coverage

2021 ◽  
Vol 53 (1) ◽  
pp. 384-390
Author(s):  
Aleksi Hämäläinen ◽  
Riitta-Liisa Patovirta ◽  
Ella Mauranen ◽  
Sari Hämäläinen ◽  
Irma Koivula
Keyword(s):  
Influenza Vaccination ◽  
Vaccination Coverage ◽  
Healthcare Workers ◽  
Seasonal Influenza ◽  
Vaccination Policy ◽  
Seasonal Influenza Vaccination

scholarly journals Using general practice data to monitor influenza vaccination coverage in the medically at risk: a data linkage study

BMJ Open ◽  
2019 ◽  
Vol 9 (9) ◽  
pp. e031802
Author(s):  
Dauda Badmus ◽  
Robert Menzies
Keyword(s):  
Risk Factors ◽  
At Risk ◽  
General Practice ◽  
Influenza Vaccination ◽  
Vaccination Coverage ◽  
Risk Groups ◽  
Medical Risk ◽  
Medical Risk Factors ◽  
Adult Vaccination ◽  
The Impact

ObjectiveTo examine the possibility of using data from a network of Australian General Practices (GPs) to estimate influenza vaccination coverage in Australians medically at risk.DesignData electronically extracted from a large national network of Australian GP clinics (MedicineInsight) was analysed for annual influenza vaccination coverage from 2008 to 2014. We compared the results with the 2009 and 2014 Adult Vaccination Survey. We adjusted for differences in the distribution of age, risk groups and provider types.SettingAll states in Australia.ParticipantsGPs participating in MedicineInsight programme.InterventionsNot applicable.Main outcome measuresAnnual vaccination coverage across risk groups as recorded in Adult Vaccination Survey in 2009 and 2014 were compared with vaccination coverage in MedicineInsight. The impact of National Immunisation Programme expansion of free vaccine in 2010 to cover patients aged <65 years with medical risk factors.ResultsThe proportion of MedicineInsight patients aged ≥18 years and diagnosed with medical risk factors was higher in 2014 (33.2%), compared with the AVS in 2009 (25%). In 2009, influenza vaccination coverage estimates for those aged 18–64 years with medical risk factors was lower for MedicineInsight patients compared with the AVS (26% vs 36%). There was no evidence of any change in coverage between 2008 and 2014, despite the vaccine being available free of charge to this group from 2010.ConclusionGeneral practice databases have the potential to help fill the gap in vaccination coverage data in patients with medical risk factors.

scholarly journals The Impact of Missed Opportunities on Seasonal Influenza Vaccination Coverage for Healthy Young Children

2011 ◽  
Vol 17 (6) ◽  
pp. 560-564 ◽  
Author(s):  
Norma J. Allred ◽  
Katherine A. Poehling ◽  
Peter G. Szilagyi ◽  
Fan Zhang ◽  
Kathryn M. Edwards ◽  
...  
Keyword(s):  
Young Children ◽  
Influenza Vaccination ◽  
Vaccination Coverage ◽  
Seasonal Influenza ◽  
Missed Opportunities ◽  
Seasonal Influenza Vaccination ◽  
The Impact

scholarly journals 2742. The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S965-S966
Author(s):  
Eili Klein ◽  
Emily Schueller ◽  
Katie K Tseng ◽  
Arindam Nandi
Keyword(s):  
United States ◽  
Antibiotic Resistance ◽  
Influenza Vaccination ◽  
Vaccination Coverage ◽  
Seasonal Influenza ◽  
Antibiotic Use ◽  
The United States ◽  
Antibiotic Prescribing ◽  
Coverage Rates ◽  
The Impact

Abstract Background Antibiotic resistance is a cause of morbidity and mortality driven by inappropriate prescribing. In the United States, a third of all outpatient antibiotic prescriptions may be inappropriate. Seasonal influenza rates are significantly associated with antibiotic prescribing rates. The impact of influenza vaccination coverage on antibiotic prescribing is unknown. Methods We conducted a retrospective analysis of state-level vaccination coverage and antibiotic prescribing rates from 2010 to 2017. We used fixed effects regression to analyze the relationship between cumulative vaccine coverage rates for a season and the per capita number of prescriptions for systemic antibiotics for the corresponding season (January–March) controlling for temperature, poverty, healthcare infrastructure, population structure, and vaccine effectiveness. Results Rates of vaccination coverage ranged from 33% in Nevada to 52% in Rhode Island for the 2016–2017 season, while antibiotic use rates ranged from 25 prescriptions per 1,000 inhabitants in Alaska to 377 prescriptions per 1,000 inhabitants in West Virginia (Figure 1). Vaccination coverage rates were highly correlated with reduced prescribing rates, and controlling for other factors, we found that a one percent increase in the influenza vaccination rate was associated with 1.40 (95% CI: 2.22–0.57, P < 0.01) fewer antibiotic prescriptions per 1,000 inhabitants (Table 1). Increases in the vaccination coverage rate in the pediatric population (aged 0–18) had the strongest effect, followed by the elderly (aged 65+). Conclusion Vaccination can reduce morbidity and mortality from seasonal influenza. Though coverage rates are far below levels necessary to generate herd immunity, we found that higher coverage rates in a state were associated with lower antibiotic prescribing rates. While the effectiveness of the vaccine varies from year to year and the factors that drive antibiotic prescribing rates are multi-factorial, these results suggest that increased vaccination coverage for influenza would have significant benefit in terms of reducing antibiotic overuse and correspondingly antibiotic resistance. Disclosures All authors: No reported disclosures.

scholarly journals Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009

2010 ◽  
Vol 15 (44) ◽  
Author(s):  
J Mereckiene ◽  
S Cotter ◽  
F D'Ancona ◽  
C Giambi ◽  
A Nicoll ◽  
...  
Keyword(s):  
European Union ◽  
Influenza Vaccination ◽  
Older Adult ◽  
Vaccination Coverage ◽  
Seasonal Influenza ◽  
Adult Population ◽  
Risk Groups ◽  
World Health ◽  
Term Care ◽  
Older Adult Population

In 2009 the second cross-sectional web-based survey was undertaken by the Vaccine European New Integrated Collaboration Effort (VENICE) project across 27 European Union (EU) member states (MS), Norway and Iceland (n=29) to determine changes in official national seasonal influenza vaccination policies since a survey undertaken in 2008 and to compare the estimates of vaccination coverage between countries using data obtained from both surveys. Of 27 responding countries, all recommended vaccination against seasonal influenza to the older adult population. Six countries recommended vaccination of children aged between six months and <18 years old. Most countries recommended influenza vaccination for those individuals with chronic medical conditions. Recommendations for vaccination of healthcare workers (HCW) in various settings existed in most, but not all countries. Staff in hospitals and long-term care facilities were recommended vaccination in 23 countries, and staff in out-patient clinics in 22 countries. In the 2009 survey, the reported national estimates on vaccine coverage varied by country and risk group, ranging from 1.1% - 82.6% for the older adult population; to between 32.9% -71.7% for clinical risk groups; and from 13.4% -89.4% for HCW. Many countries that recommend the influenza vaccination do not monitor the coverage in risk groups. In 2008 and 2009 most countries recommended influenza vaccination for the main risk groups. Hovewer, despite general consensus and recommendations for vaccination of high risk groups many countries do not achieve high coverage in these groups. The reported vaccination coverage still needs to be improved in order to achieve EU and World Health Organization goals.

Sign in / Sign up

Export Citation Format

Share Document